Search Count: 29
 |
Cryo-Em Structure Of The C. Neoformans Lipid Flippase Apt1-Cdc50 Bound With Butyrolactol A In The E2P State
Organism: Cryptococcus neoformans var. grubii h99
Method: ELECTRON MICROSCOPY Release Date: 2025-10-22 Classification: TRANSLOCASE/INHIBITOR Ligands: NAG, BEF, MG, A1BD6 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: CYTOKINE Ligands: A1CB1 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: CYTOKINE Ligands: A1CB0 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: CYTOKINE Ligands: A1CBZ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: CYTOKINE Ligands: A1CCE |
 |
Crystal Structure Of The Human Pxr Ligand-Binding Domain In Complex With Furanodienone
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-04-16 Classification: TRANSCRIPTION Ligands: XFQ |
 |
Cryo-Em Structure Of The C. Neoformans Lipid Flippase Apt1-Cdc50 Bound With Butyrolactol A In The E2P State
Organism: Cryptococcus neoformans var. grubii h99
Method: ELECTRON MICROSCOPY Release Date: 2025-02-05 Classification: TRANSLOCASE/INHIBITOR Ligands: NAG, BEF, MG, A1BD6 |
 |
Cryo-Em Structure Of The C. Neoformans Lipid Flippase Apt1-Cdc50 In The E1 State
Organism: Cryptococcus neoformans var. grubii h99
Method: ELECTRON MICROSCOPY Release Date: 2025-02-05 Classification: LIPID TRANSPORT Ligands: NAG, MG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2024-09-04 Classification: DNA BINDING PROTEIN Ligands: HEZ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2024-04-03 Classification: CYTOKINE Ligands: XCE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2024-04-03 Classification: CYTOKINE Ligands: XCW, CL |
 |
Discovery Of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate In Vivo Activity In Mouse Xenograft Models Of Human Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2019-04-17 Classification: APOPTOSIS Ligands: KJP |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Direct Covalent Modification Of His315 With Cmpd1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2018-07-25 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: CA, ICT, DWP |
 |
Novel Binding Modes Of Inhibition Of Wild-Type Idh1: Allosteric Inhibition With Cmpd2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2018-07-25 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: LMR, MG, K32 |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Non-Equivalent Allosteric Inhibition With Cmpd3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2018-07-25 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NAP, DWM |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1:Direct Covalent Modification Of His315 With Cmpd11
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2018-07-25 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: MG, ICT, DWJ, NAP |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Direct Covalent Modification Of His315 With Cmpd13
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2018-07-25 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: ICT, DWG, CA |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Direct Covalent Modification Of His315 With Cmpd15
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2018-07-25 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: CA, ICT, DWS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2018-01-31 Classification: APOPTOSIS Ligands: ECY |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2018-01-31 Classification: APOPTOSIS Ligands: ECM |